Chnoospora minima: a Robust Candidate for Hyperglycemia Management, Unveiling Potent Inhibitory Compounds and Their Therapeutic Potential

IF 2.6 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Thilina Lakmini Gunathilaka, Upeka Bandaranayake, Mohamad Boudjelal, Rizwan Ali, Rajitha M. Silva, Kalpa W. Samarakoon, Pathmasiri Ranasinghe, L. Dinithi C. Peiris
{"title":"Chnoospora minima: a Robust Candidate for Hyperglycemia Management, Unveiling Potent Inhibitory Compounds and Their Therapeutic Potential","authors":"Thilina Lakmini Gunathilaka, Upeka Bandaranayake, Mohamad Boudjelal, Rizwan Ali, Rajitha M. Silva, Kalpa W. Samarakoon, Pathmasiri Ranasinghe, L. Dinithi C. Peiris","doi":"10.1007/s10126-024-10368-y","DOIUrl":null,"url":null,"abstract":"<p>The present study aimed to isolate a bioactive compound from Sri Lankan edible marine brown algae, <i>Chnoospora minima</i>, to manage diabetes. The de-polysaccharide crude methanolic extract was partitioned using hexane, chloroform, and ethyl acetate with increased polarity. The samples were subjected to determine the quantitative phytochemical analysis, antioxidants, and antidiabetic potentials. Further, the potent antidiabetic fraction was selected to isolate an active compound using bioactivity-guided fractionation. From the selected extract, the chloroform fraction exhibited comparatively high TPC (59.01 ± 1.86 mg GAE/g), TFC (5.14 ± 0.43 mg QE/g) and alkaloid content (2.79 ± 0.31 PE/g of extract). Crude methanol extract exhibited a potent DPPH activity (IC<sub>50</sub>: 0.48 ± 0.01 mg/mL) whereas the ethyl acetate fraction elicited a maximum ABTS activity (IC<sub>50</sub>: 0.064 ± 0.001 mg/mL) and a ferrous iron–chelating capacity (IC<sub>50</sub>: 0.019 mg/mL). Similarly, the chloroform fraction exhibited the highest FRAP (20.34 ± 1.72 mg TE/g) and ORAC (19.72 ± 2.92 mg TE/g) capacities. The potent inhibitory activity of α-amylase (IC<sub>50</sub>:3.17 ± 0.02 µg/mL) and α-glucosidase (IC<sub>50</sub>: 1.99 ± 0.01 µg/mL) enzymes and glucose diffusion was observed in the chloroform fraction. Similarly, the chloroform extract exhibited a potent BSA-glucose (IC<sub>50</sub>: 202.43 ± 5.71 µg/mL), BSA-MGO (IC<sub>50</sub>: 124.30 ± 2.85 µg/mL) antiglycation model and reversing activities (EC<sub>50BSAglucose</sub>: 98.99 ± 0.35 µg/mL; EC<sub>50BSA-MGO</sub>: 118.89 ± 1.58 µg/mL). Depending on the hypoglycemic activity, fucoxanthin was isolated as the active compound which showed a notable change in the functional group. Molecular docking studies were conducted on the compound, and binding energy was observed to be − 6.56 kcal/mol and − 4.83 kcal/mol for α-amylase and α-glucosidase enzymes, respectively, which confirmed the hypoglycemic effect of the isolated compounds. However, more studies are required to understand the mechanistic insights of these observations.</p>","PeriodicalId":690,"journal":{"name":"Marine Biotechnology","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marine Biotechnology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10126-024-10368-y","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The present study aimed to isolate a bioactive compound from Sri Lankan edible marine brown algae, Chnoospora minima, to manage diabetes. The de-polysaccharide crude methanolic extract was partitioned using hexane, chloroform, and ethyl acetate with increased polarity. The samples were subjected to determine the quantitative phytochemical analysis, antioxidants, and antidiabetic potentials. Further, the potent antidiabetic fraction was selected to isolate an active compound using bioactivity-guided fractionation. From the selected extract, the chloroform fraction exhibited comparatively high TPC (59.01 ± 1.86 mg GAE/g), TFC (5.14 ± 0.43 mg QE/g) and alkaloid content (2.79 ± 0.31 PE/g of extract). Crude methanol extract exhibited a potent DPPH activity (IC50: 0.48 ± 0.01 mg/mL) whereas the ethyl acetate fraction elicited a maximum ABTS activity (IC50: 0.064 ± 0.001 mg/mL) and a ferrous iron–chelating capacity (IC50: 0.019 mg/mL). Similarly, the chloroform fraction exhibited the highest FRAP (20.34 ± 1.72 mg TE/g) and ORAC (19.72 ± 2.92 mg TE/g) capacities. The potent inhibitory activity of α-amylase (IC50:3.17 ± 0.02 µg/mL) and α-glucosidase (IC50: 1.99 ± 0.01 µg/mL) enzymes and glucose diffusion was observed in the chloroform fraction. Similarly, the chloroform extract exhibited a potent BSA-glucose (IC50: 202.43 ± 5.71 µg/mL), BSA-MGO (IC50: 124.30 ± 2.85 µg/mL) antiglycation model and reversing activities (EC50BSAglucose: 98.99 ± 0.35 µg/mL; EC50BSA-MGO: 118.89 ± 1.58 µg/mL). Depending on the hypoglycemic activity, fucoxanthin was isolated as the active compound which showed a notable change in the functional group. Molecular docking studies were conducted on the compound, and binding energy was observed to be − 6.56 kcal/mol and − 4.83 kcal/mol for α-amylase and α-glucosidase enzymes, respectively, which confirmed the hypoglycemic effect of the isolated compounds. However, more studies are required to understand the mechanistic insights of these observations.

Abstract Image

Chnoospora minima:高血糖管理的有力候选者,揭示强效抑制化合物及其治疗潜力
本研究旨在从斯里兰卡可食用海洋褐藻 Chnoospora minima 中分离出一种生物活性化合物,用于控制糖尿病。使用正己烷、氯仿和乙酸乙酯对去多糖粗甲醇提取物进行极性分馏。对样品进行了定量植物化学分析、抗氧化剂和抗糖尿病潜力测定。此外,还利用生物活性指导分馏法选出了有效的抗糖尿病馏分,以分离出活性化合物。从所选提取物中,氯仿馏分显示出相对较高的 TPC(59.01 ± 1.86 mg GAE/g)、TFC(5.14 ± 0.43 mg QE/g)和生物碱含量(2.79 ± 0.31 PE/g)。甲醇粗萃取物具有强效的 DPPH 活性(IC50:0.48 ± 0.01 mg/mL),而乙酸乙酯馏分则具有最大的 ABTS 活性(IC50:0.064 ± 0.001 mg/mL)和亚铁螯合能力(IC50:0.019 mg/mL)。同样,氯仿馏分表现出最高的 FRAP(20.34 ± 1.72 毫克 TE/克)和 ORAC(19.72 ± 2.92 毫克 TE/克)能力。氯仿萃取物对α-淀粉酶(IC50:3.17 ± 0.02 µg/mL)和α-葡萄糖苷酶(IC50:1.99 ± 0.01 µg/mL)酶和葡萄糖扩散具有强效抑制活性。同样,氯仿萃取物也表现出有效的 BSA-葡萄糖(IC50:202.43 ± 5.71 µg/mL)、BSA-MGO(IC50:124.30 ± 2.85 µg/mL)抗糖化模型和逆转活性(EC50BSAglucose:98.99 ± 0.35 µg/mL;EC50BSA-MGO:118.89 ± 1.58 µg/mL)。根据降血糖活性的不同,分离出的岩藻黄素是活性化合物,其官能团发生了显著变化。对化合物进行了分子对接研究,观察到α-淀粉酶和α-葡萄糖苷酶的结合能分别为- 6.56 kcal/mol 和- 4.83 kcal/mol,这证实了分离化合物的降血糖作用。然而,要了解这些观察结果的机理,还需要更多的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Marine Biotechnology
Marine Biotechnology 工程技术-海洋与淡水生物学
CiteScore
4.80
自引率
3.30%
发文量
95
审稿时长
2 months
期刊介绍: Marine Biotechnology welcomes high-quality research papers presenting novel data on the biotechnology of aquatic organisms. The journal publishes high quality papers in the areas of molecular biology, genomics, proteomics, cell biology, and biochemistry, and particularly encourages submissions of papers related to genome biology such as linkage mapping, large-scale gene discoveries, QTL analysis, physical mapping, and comparative and functional genome analysis. Papers on technological development and marine natural products should demonstrate innovation and novel applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信